RightAnswer Knowledge Solutions provides access to hundreds of data sources. Our premier and proprietary sources include fully-researched documents from well-established experts in the chemical and HazMat fields.
A search in our system for this chemical would return results – all in one place -- in the following categories from the listed data sources.
- Chemical Identification
- Environmental Hazards
- First Aid/Medical Treatment
- Handling/Storage/Shipping/Waste Management
- MSDS Documents
- Personal Protection
- Physical Hazards/Corrective Response Actions
- Physical/Chemical Properties
- Report Abstracts and Studies
- Reproductive Risk
- Toxicology/Health Hazards/Exposure
|Example of Acute Exposure data from MEDITEXT.|
RightAnswer Proprietary Data Sources:
Other Government Links Searched via RegsKnowledge:
State Environmental Regulations
Example Content from MEDITEXT for 154-42-7:
Please note: this is an extract of information from a larger document. Full document and details are available by subscription.
ACUTE EXPOSURE INFORMATION
- WITH THERAPEUTIC USE
- Dose-limiting bone marrow suppression is the most frequent adverse effect. Patients with an inherited deficiency of thiopurine methyltransferase may develop rapid bone marrow suppression following the initiation of treatment. Additionally hepatotoxicity, hyperuricemia, nausea and vomiting, anorexia, and stomatitis have been reported following thioguanine administration.
- WITH POISONING/EXPOSURE
- There are no published reports of overdose at the time of this review. The manufacturer reports that signs and symptoms after overdose may be immediate, such as nausea and vomiting, malaise, hypertension, and diaphoresis, or delayed, such as myelosuppression and azotemia. Reversible myelosuppression has been reported following the ingestion of a single oral dose of thioguanine 35 mg/kg.
© 2011-2019 RightAnswer.com, Inc. and/or its licensors. All rights reserved. No claim to original U.S. Govt. works.